Latest Posts

27

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More

18

Mar 24

Innovative AI technology in oncology: Partex Group presents results from a pilot project

During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY

Meet us in Paris to interact with key opinion leaders and learn first-hand about practice challenges and controversies in oncology.

Participants:

– Dr. Mads Dalgaard – Chief Executive Officer, Cureteq AG

– Ph.D. Marie-Christine Bissery – Chief Science Officer, Cureteq AG

– Dr. Stephan Braun – Chief Medical Officer – Cureteq AG

– Prof. Dr. Dr. med. Juergen Scheele – Chief Medical Officer, Innoplexus AG

– Ms. Dafina Taqi – Support Project Manager, Innoplexus AG

– Ms. Claudia M. Hausoel – Chief Marketing Officer, Innoplexus AG

– Ms. Eleni Zisimopoulou – Medical Information Specialist, Innoplexus AG

Date: September 09-13, 2022

Venue: Expo Porte de Versailles, Paris France

Read more

EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY